Regulus Gains License for IP on Immuno-inflammatory microRNAs from California Institute of Technology
News Dec 18, 2009
Regulus Therapeutics Inc. announce that it has obtained exclusive rights from the California Institute of Technology to inventions made in the laboratory of David Baltimore, Ph.D. covering methods and compositions for modulating microRNA-146 and microRNA-155.
Dr. Baltimore and his colleagues have shown that microRNAs miR-146 and miR-155 are key mediators of the inflammatory response. Modulation of these microRNAs could lead to a new method of treating immune-inflammatory disease.
“We are very pleased to obtain exclusive worldwide rights to this intellectual property from California Institute of Technology, as it builds on our strategy of consolidating and controlling the key intellectual property needed for the development of microRNA therapeutics,” said Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer of Regulus. “Access to this intellectual property allows us to apply our expertise in the biology of microRNAs and nucleic acid chemistry to translate academic discoveries into novel microRNA-based therapeutics for inflammatory diseases.”
The licensed technology relates to the discovery that miR-155 is induced during the macrophage inflammatory response and the characterization of miR-155 as a common target of a broad range of inflammatory mediators. As miR-155 is known to function as an oncogene, these observations suggest a link between inflammation and cancer.
Also included in the licensed technology is the discovery that miR-146 is induced, in an NF-kB-dependent manner, in response to proinflammatory mediators. These findings suggest that modulation of miR-146 may be of therapeutic benefit in treating diseases characterized by excessive activation of innate immunity signaling.
Habitat loss, habitat fragmentation and the loss of genetic diversity are the main factors driving the extinction of many wild species, and the few eastern massasauga rattlesnakes remaining in Illinois have certainly suffered two of the three. A long-term study of these snakes reveals, however, that – despite their alarming decline in numbers – they have retained a surprising amount of genetic diversity.READ MORE
Researchers have discovered a navigational gene in glass catfish called the electromagnetic-perceptive gene, or EPG, that responds to certain magnetic waves. These findings have the potential to revolutionize treatments for humans and help those who suffer from tremors related to Parkinson’s and seizures associated with epilepsy.